IL203788A - Use of antibodies which bind the og domain of mmp-9 for the preparation of medicaments - Google Patents
Use of antibodies which bind the og domain of mmp-9 for the preparation of medicamentsInfo
- Publication number
- IL203788A IL203788A IL203788A IL20378810A IL203788A IL 203788 A IL203788 A IL 203788A IL 203788 A IL203788 A IL 203788A IL 20378810 A IL20378810 A IL 20378810A IL 203788 A IL203788 A IL 203788A
- Authority
- IL
- Israel
- Prior art keywords
- mmp
- medicaments
- antibodies
- bind
- domain
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL203788A IL203788A (en) | 2007-08-15 | 2010-02-08 | Use of antibodies which bind the og domain of mmp-9 for the preparation of medicaments |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93548607P | 2007-08-15 | 2007-08-15 | |
PCT/IL2008/001082 WO2009022328A2 (en) | 2007-08-15 | 2008-08-07 | Regulators of mmp-9 and uses therof |
IL203788A IL203788A (en) | 2007-08-15 | 2010-02-08 | Use of antibodies which bind the og domain of mmp-9 for the preparation of medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
IL203788A true IL203788A (en) | 2015-02-26 |
Family
ID=52594848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL203788A IL203788A (en) | 2007-08-15 | 2010-02-08 | Use of antibodies which bind the og domain of mmp-9 for the preparation of medicaments |
Country Status (1)
Country | Link |
---|---|
IL (1) | IL203788A (en) |
-
2010
- 2010-02-08 IL IL203788A patent/IL203788A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181616T1 (en) | Fully human anti-vap-1 monoclonal antibodies | |
EP2109625A4 (en) | Use of antibody conjugates | |
EP2152290A4 (en) | Methods for administering anti-il-5 antibodies | |
IL196470A (en) | Antagonist antibody for the treatment of cancer | |
SG10201604258YA (en) | Anti-tnf antibody formulations | |
HRP20130320T1 (en) | Anti-myostatin antibodies | |
GB0708002D0 (en) | Antibodies | |
HK1207652A1 (en) | Antibody formulations | |
IL202648A0 (en) | Antibody formulations | |
HK1136970A1 (en) | Penta-specific antibody | |
EP2173163A4 (en) | Antibody formulations | |
EP2138576A4 (en) | Anti-claudin-4 antibody | |
EP2172483A4 (en) | ANTI-Muc17 ANTIBODY | |
HK1153502A1 (en) | Anti-bst2 antibody bst2 | |
GB0718737D0 (en) | Antibodies | |
IL197632A0 (en) | Use of jam-c binding compounds | |
ZA201003729B (en) | Conjugates of anti-rg-1 antibodies | |
IL203788A (en) | Use of antibodies which bind the og domain of mmp-9 for the preparation of medicaments | |
EP2167635A4 (en) | Antibody formulations | |
GB0723900D0 (en) | Lyophillised antigen composition | |
GB0723044D0 (en) | Lyophillised antigen composition | |
AU2007907021A0 (en) | Antibodies for the treatment of periodontal disease | |
GB0724185D0 (en) | Antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
NP | Permission for amending the patent specification granted (section 66, patents law 1967) | ||
MM9K | Patent not in force due to non-payment of renewal fees |